"Mary Greeley is a 220-bed regional hospital that provides healthcare to the residents of a 13-county area in central Iowa. The counties include Story, Boone, Marshall, Greene, Hamilton, Hardin, Sac, Calhoun, Wright, Carroll, Tama, Dallas and Polk."

During the past decade, Mary Greeley Medical Center conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 54 clinical trials were completed, i.e. on average, 39.4% percent of trials that started reached the finish line to date. In the past 5 years, 67 clinical trials started and 36 clinical trials were completed. i.e. 53.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mary Greeley Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 93 trials, followed by "SWOG Cancer Research Network" with 39 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "NRG Oncology" with 17 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Greeley Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 97 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Mary Greeley Medical Center" are "Stage IV Lung Cancer AJCC v8" (13 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IVA Lung Cancer AJCC v8" (9 trials), "Stage IVB Lung Cancer AJCC v8" (9 trials) and "Invasive Breast Carcinoma" (8 trials). Many other conditions were trialed in "Mary Greeley Medical Center" in a lesser frequency.

Most popular intervention types in "Mary Greeley Medical Center" are "Drug" (158 trials), "Other" (123 trials), "Biological" (86 trials), "Procedure" (60 trials) and "Radiation" (26 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (58 trials), "Laboratory Biomarker Analysis" (52 trials), "Questionnaire Administration" (37 trials), "Computed Tomography" (35 trials) and "Biospecimen Collection" (33 trials). Other intervention names were less common.

The vast majority of trials in "Mary Greeley Medical Center" are 165 trials for "All" genders, 23 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Mary Greeley Medical Center". undefined are not yet recruiting, 76 are recruiting, 84 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Mary Greeley Medical Center, 3 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Mary Greeley Medical Center, 3 "Phase 1" clinical trials were conducted, 102 "Phase 2" clinical trials and 98 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".